Gastrointestinal parasites are commonly diagnosed in captive tortoises. In response, fenbendazole has traditionally been used as an anthelmintic, either in single or repeated doses. However, fenbendazole requires oral administration and the process can be very challenging in some individuals. A topical preparation containing emodepside and praziquantel (Profender ® , Bayer, Leverkusen, Germany) is promoted as effective against a broad range of nematodes, trematodes, and cestodes. Although this product is currently only licensed for administration to cats, previous studies have shown positive results with tortoises. The aim of this study was to determine the efficacy of Profender against oxyurid and ascarid parasites in captive tortoises. This was achieved by quantifying nematode eggs per gram (EPG) in feces using a modified McMaster technique before (Day 0) and after (Days 14 and 33) topical application of Profender at a dose rate of 21.5 mg emodepside and 85.5 mg praziquantel per kilogram. Twenty-nine tortoises, representing four different species, were enrolled in this study of which 14 (48%; including Testudo hermanni and Testudo graeca) were positive for intestinal nematodes. Following treatment, the oxyurid EPG was slightly increased on Day 14 but declined significantly by Day 33 (59.7% reduction; P = 0.01), indicating a slow onset of effect and moderate efficacy 33 days posttreatment; however, no conclusions regarding efficacy against ascarids can be drawn from this study. Topical application of emodepside and praziquantel was well tolerated in our tortoise population and, therefore, could be considered as a useful alternative anthelmintic treatment protocol for captive tortoises.
IntroductIon
Endoparasites are commonly diagnosed in chelonians, and gastrointestinal helminthiasis has previously been reported to be the most commonly presented condition in tortoises (Holt et al., 1979) . Although many endoparasites are minimally pathogenic, some may require therapeutic intervention, and stressful or suboptimal environments are likely to exacerbate the outcome of infection in captive terrestrial species (Wilson and Carpenter, 1996; Pasmans et al., 2008) . Intestinal nematodes such as oxyurids and ascarids are frequently detected during routine fecal screening in captive tortoises in the UK, although the significance of health concerns associated with nematodiasis in tortoises remain uncertain (Hedley et al., 2013) .
Oxyurids are the most frequently identified nematodes in tortoises, especially in Hermann's tortoises (Testudo hermanni) (Buńkowska et al., 2011; Rataj et al., 2011 ). There are a wide variety of oxyurid worms that can affect tortoises, including species within the genera Tachygonetria, Spauligodon, Aleuris, Thelandros, Mehdiella, Ortleppnema, and Thaparia (Greiner and Mader, 2006) , and coinfection is common (Matsuo et al., 1999; Greiner and Mader, 2006) . In the absence of reported variation in pathogenicity or anthelmintic susceptibility between individual parasite species, the oxyurids will not be discussed individually in this article. Oxyurids have a direct life cycle, and most appear to be host specific (Telford, 1971) . Infected tortoises are usually asymptomatic, and a largely hostparasite relationship has been established in the gut of many tortoises (McArthur et al., 2004) . Oxyurid parasites commonly inhabit the lower intestinal tract of tortoises, where it has been suggested that they may help break down fecal content and reduce the occurrence of constipation (Frank, 1981) . However, high levels of parasitaemia have been associated with fatal post-hibernation anorexia in tortoises (Wilson and Carpenter, 1996) , potentially as a consequence of nutrient deprivation to the host. Intestinal impaction has also been documented in severe infestations (Frank, 1981) . A rise in oxyurid eggs detected in feces has been reported after hibernation, demonstrating their ability to survive the hibernation period, especially in young tortoises (Traversa et al., 2005) .
Angusticaecum holopterum is the most common ascarid identified in herbivorous tortoises (Holt et al., 1979; Frank, 1981; Traversa et al., 2005) . Ascarids are relatively large parasites; adult worms can reach up to 10 cm in length (Frank, 1981) . They are located in the gastrointestinal tract and may be found attached to the intestinal mucosa of their host. Angusticaecum holopterum tend to have direct life cycles, and infection of the host follows ingestion of an embryonated egg (McArthur et al., 2004; Hedley et al., 2013) . Gastrointestinal lesions may occur attributable to the migration of larvae through the viscera or embedding of adults within the mucosa (McArthur et al., 2004) . Low numbers of ascarids are unlikely to cause disease, but intestinal obstruction or perforation has been reported in tortoises with heavy burdens of adult ascarids (Keymer, 1978; Sprent, 1984; Wilson and Carpenter, 1996) , in addition to anorexia and vomiting of worms (Holt et al., 1979) . This might be more likely to occur following anthelmintic treatment due to the accumulation of dead worms in the large intestine (Sprent, 1984) . Other pathologies that have been associated with ascaridiasis include intussusception, gastrointestinal ulceration, coelomitis, thromboembolism, and avascular necrosis (Frye, 1991) .
Fenbendazole has been used as an anthelmintic in tortoises for decades, either in single or repeated doses (Benson, 1999; Carpenter, 2005; Giannetto et al., 2007) . It is widely regarded as a safe anthelmintic drug with a broad margin of safety and is reported to be well tolerated by tortoises (Fitzgerald and Newquist, 2008) . However, there has been a single report indicating an association between clinicopathologic alternations (including heteropenia, transient hypoglycaemia, hyperuricaemia, and hyperphosphataemia) and the administration of fenbendazole in parasitized tortoises (Neiffer et al., 2005) . There is also recent anecdotal evidence of reduced fenbendazole efficacy in chelonians (Pellett et al., 2014) . Fenbendazole is usually administered orally. This can however be a stressful experience and carries a risk of trauma, so it may be impractical in some tortoises. Russian tortoises (Testudo horsfieldii) and leopard tortoises (Stigmochelys pardalis) are particularly uncooperative and challenging for oral administration of drugs (Brames, 2008) . Consequently, there is a necessity to assess alternative anthelmintic options, which could be administered by a more practical route.
Emodepside belongs to a relatively new class of anthelmintics (cyclooctadepsipeptides) that achieve their anthelmintic activity by a novel mode of action . Emodepside acts at neuromuscular junctions to trigger release of an inhibitory neurotransmitter by stimulating the presynaptic receptors, inducing a flaccid paralysis in nematodes Harder et al., 2005) . Previous studies in a wide range of companion and livestock animals, including chickens, mice, rats, dogs, cats, sheep, cattle, and horses, have shown that emodepside displays effective anthelmintic activity against a number of gastrointestinal nematodes (Fukashe et al., 1990; Sasaki et al., 1992; von Samson-Himmelstjerna et al., 2000) . Praziquantel is a broadly effective anthelmintic drug with activity against trematodes and cestodes (Andrews, 1985) . Praziquantel works by increasing the permeability of Ca 2+ channels, causing an excessive influx of Ca 2+ across muscle and/or tegumental membranes of parasites (Martin, 1997) . This rapidly causes tegumental damage and spastic paralysis of the parasite, and increases exposure of parasite antigens at the worm surface which makes them more vulnerable to host antibody-dependent immunity (Harnett and Kusel, 1986) . A commercially available topical preparation containing emodepside and praziquantel (Profender ® , Bayer, Leverkusen, Germany) has been licensed for application to cats in the UK since 2005 (European Medicine Agency, 2008). Profender has been tested for drug absorption and efficacy after topical application in a wide range of reptile species (chelonians, lizards, and snakes) with the studies demonstrating promising results in all subjects and no treatment-related adverse effects observed, even at dosages 15, 30, and 50 times higher than the recommended dose for cats (Mehlhorn et al., 2005; Brames, 2008; Schilliger et al., 2009) .
The objective of this study was to evaluate the efficacy of Profender spot-on, a combination product containing emodepside and praziquantel, against oxyurids and ascarids in captive tortoises in the UK. Based on evidence from previous studies (Brames, 2008; Schilliger et al., 2009) , we hypothesized that there would be a gradual decline in the number of nematode ova excreted in feces after the topical application of Profender.
MAterIAls And Methods
This study was ethically reviewed by the Clinical Research Ethical Review Board at the Royal Veterinary College (RVC), and ethical approval was granted under the reference number URN 2016 1518. Informed consent was obtained in advance from the owners of all tortoises before enrollment.
Study Animals: A panel of 29 clinically healthy tortoises, including four different species, were located in a tortoise rehoming center in Norfolk, UK, and enrolled in this clinical trial between September and October 2016. These included 22 spur-thighed tortoises (Testudo graeca), four Hermann's tortoises, two Russian tortoises, and one leopard tortoise. Twenty-eight of the tortoises had not received anthelmintic treatment in the preceding four years. Our tortoise population was maintained in different groups but under identical husbandry conditions; all tortoises lived in outdoor greenhouses, with supplementary heat and ultraviolet B light provided, when necessary, and they were fed a naturally diverse diet of weeds and flowers, including dandelion (Taraxacum spp.), sow thistle (Sonchus spp.), mallow (Malva spp.), clover (Trifolium spp.), and nipplewort (Lapsana spp.). Fresh fecal samples were collected from the ground or water for microscopic fecal analysis.
Fecal Examination: All samples were processed using a modified McMaster egg counting technique to establish a quantitative assessment of nematode egg counts. Briefly, 3 g fecal material was measured into a plastic container. When the size of the fecal sample was limited, a minimum quantity of 1 g was used instead. For flotation, salt/sugar solution (400 g sodium chloride, 500 g sugar, dissolved in 1 L distilled water) with a specific gravity of 1.28 was added at a 14:1 (v/w) ratio and mixed well with the feces. The mixture was stirred and pipetted to fill up both chambers of a McMaster counting chamber. Both grids were visualized under the microscope at 100× total magnification. Images were captured using a digital camera. Identification of oxyurid and ascarid eggs was based on the distinct morphological descriptions of ova (McArthur et al., 2004; Greiner and Mader, 2006; Jacobson, 2007) , and the number of worm eggs present was recorded. Results were presented as "eggs per gram" (EPG) of feces (EPG = total number of eggs in both grids × 50).
Determination of Anthelmintic Efficacy:
Tortoises with EPG in excess of 400 helminth eggs were selected for treatment. These tortoises were treated topically by the veterinary surgeon with a single dose of Profender applied to the prefemoral fossa at 1mL/kg (Fig. 1) , corresponding to 21.5 mg emodepside and 85.5 mg praziquantel per kg (off-label); this dose was chosen to be consistent with previous studies (Brames, 2008; Schilliger et al., 2009) . The dosage used in this study was seven times higher than the licensed dose for cats (Brames, 2008) , in part attributable to the thick stratum corneum of the tortoise epidermis but also limiting the potential wastage of solution.
Tortoises were returned to their usual enclosures with no alterations to their environment and husbandry throughout the study period. Their owner was requested to report any adverse reactions as soon as possible to the veterinary surgeon. On Day 14 posttreatment, feces collected from all enrolled tortoises were examined microscopically. Fecal egg counts (FEC) were repeated from the treated tortoises 33 days after treatment. Subsequently, the EPG determined pre-(Day 0) and post-worming (Days 14 and 33) were assessed, and the percentage fecal egg count reduction (FECR) of oxyurid and ascarid eggs was calculated. For individual nematodes, the arithmetic means of EPG were calculated (Dobson et al., 2009) , and the percent efficacy of Profender against individual nematode type was calculated using the formula below (Coles et al., 1992) .
Sufficient anthelmintic efficacy with no evidence of genetic resistance was defined as FECR ≥ 95% (Coles et al., 2006) .
Statistics:
Statistical analyses were conducted using SPSS Statistics version 22 (IBM Corp., Armonk, NY). The ShapiroWilk test was used to test for normality (P < 0.05). None of the parameters was found to be normally distributed; thus, nonparametric tests were used for data analysis. For individual nematodes, the Wilcoxon signed-rank test was used to compare mean EPG between the three measurement days (pretreatment, 14 and 33 days posttreatment), and the criterion for statistical significance was a P < 0.05. Statistical testing was not performed for individual tortoise species because of the small sample sizes.
results
Pretrial Screening: During pre-trial screening, 15 (Day 0; 52%) of the tortoises had no worm eggs detected by fecal examination. In total, 14 (48%) of the tortoises were positive, all with EPG ≥ 400, including 11 T. graeca and 3 T. hermanni. Of these, 11 (79%; 8/22 T. graeca and 3/4 T. hermanni) included oxyurid-type eggs (Fig. 2) , and 3 (21%; 3/22 T. graeca) included ascarid eggs putatively identified as A. holopterum (Fig. 3) . No tortoises were found to be co-infected with both nematode types (Fig. 4 ).
Posttreatment Screening: Fecal screening 14 days posttreatment revealed a slight, albeit not significant, increase in oxyurid EPG of 6% across all infected tortoises (P = 0.93; Table 1 Figure 1. Profender ® was applied to the prefemoral fossa at 1 mL/kg using a disposable syringe. and Fig. 5) . By Day 33, oxyurid EPG was significantly decreased (59.7%; P = 0.01).
The percentage reduction in ascarid EPG was 66.9% by Day 14 (P = 0.109; Table 1 ). As one of just three Day 33 posttreatment fecal samples was unavailable, the Day 33 median ascarid EPG, efficacy percentage and P-value were not calculated, although the individual FECR figures were 100% and 18%, respectively.
Of the 15 tortoises found to be uninfected during pretrial screening, fecal samples were available from nine on Day 14 and all remained negative. dIscussIon Susceptibility to disease caused by parasitism can be related to a number of factors, including environmental temperatures and cleanliness, stress, concurrent disease, parasite burden, nutritional status, and age of the host (Wilson and Carpenter, 1996) . In some tortoises, therapeutic intervention may be required in response to parasite infection. Fenbendazole has been commonly used as an anthelmintic in many reptiles, including tortoises (Carpenter, 2005; Giannetto et al., 2007) . To date, there is no alternative product available on the market in the UK, whereas the safety and efficacy of other anthelmintics is yet to be demonstrated in a wide array of tortoise species.
One possible alternative is Profender, although previous studies have yielded conflicting results. One clinical study with 103
Russian tortoises (T. horsfieldii) showed a slight increase of oxyurid EPG 15 days after application of Profender at 1 mL/kg and an overall oxyurid EPG reduction of 69% by 29 days (Brames, 2008) . However, another study reported a complete cessation of oxyurid and ascarid egg excretion 14 days after Profender treatment at 1.12 mL/kg (Schilliger et al., 2009) , whereas one other reported the absence of nematode eggs 24 h after topical Profender application at a lower dose of 0.56 mL/ kg (Mehlhorn et al., 2005) . It is challenging to explain the disagreement between these results, although the inconsistency may be attributable to host or parasite species variation, husbandry factors, and/or the different fecal egg detection and counting techniques used in these studies. As a result, an efficacy study for Profender in a real-life clinical scenario is warranted. To the authors' knowledge, this study is the first to report the efficacy of Profender against oxyurids in spur-thighed and Hermann's tortoises, including quantitative data using the modified McMaster egg counting technique. In the study reported here, the dosage of 1 mL Profender/ kg bodyweight applied topically to the prefemoral fossa demonstrated delayed, moderate anthelmintic activity against oxyurids in tortoises. No statistically significant change in mean oxyurid EPG was detected 14 days after the administration of Profender, followed by a significant reduction of 59.7% by Day 33. Our findings concur with those from a previously published report, which also showed an initial slight increase in oxyurid EPG in a large group of Russian tortoises 15 days after Profender administration (Brames, 2008) . This initial discouraging result could be explained by a slow onset of effect for Profender, potentially associated with the relatively thick and less permeable skin of tortoises. Absorption of both ingredients in Profender has been proven to be successful in tortoises in a previous pharmacokinetic study, although a comparatively longer period of time was required to achieve therapeutic levels in the blood (Schilliger et al., 2009) . It is possible that oxyurid EPG would have continued to decrease after our study period of 33 days, but such investigation was not possible within the framework of the study. Explanations for the incomplete efficacy by Day 33 may include a possible requirement for a longer time frame for emodepside to exert a complete effect against oxyurids in tortoises, or the occurrence of anthelmintic resistance in oxyurids to emodepside in tortoises. However, complete elimination of oxyurids is often not possible (Mitchell, 2007) . The efficacy of Profender against oxyurids in our tortoises did not reach 95% and was less than that reported in other published studies (Mehlhorn et al., 2005; Brames, 2008; Schilliger et al., 2009) , although it should be noted that a substantial decline in EPG was detected, which would reduce the extent of environmental contamination. Direct comparison with fenbendazole from the published literature is difficult, although a study using two fenbendazole doses at 100 mg/kg 14 days apart in 77 tortoises prompted a 85.5% reduction in oxyurid EPG seven days after the second treatment (Pellett et al., 2014) , suggesting that this fenbendazole protocol was more effective against oxyurids in tortoises than Profender. Nonetheless, in situations where oral administration is challenging, Profender spot-on can provide closely comparable efficacy for deworming because no safe and effective injectable anthelmintic is currently available for the use in tortoises. Ivermectin is an injectable anthelmintic that works against nematodes; however, chelonians are generally highly susceptible to ivermectin toxicosis, and this can result in paresis, flaccid paralysis, hepatic lipidosis, nephrotoxicity, and death (Teare and Busch, 1983; Diaz-Figueroa and Mitchell, 2006) . Therefore, the use of ivermectin should be avoided in tortoises. No treatment-related adverse effects were reported in any animals treated with Profender throughout the study.
Another potential explanation for the slow onset of effect of Profender in our study is the relatively low ambient temperature available throughout. Tortoises are ectothermic herbivores, and their metabolism is dependent on the external temperature (Pough, 1980; Lagarde et al., 2003; McArthur et al., 2004) . Appropriate ambient temperatures for Hermann's and spurthighed tortoises have been suggested to be between 26°C and 30°C (78.8°F and 86°F) (McArthur et al., 2004) . Because our population of tortoises were housed in outdoor enclosures with no external heat source and the temperature of the study location was between 8°C and 18°C (46.4°F and 64.4°F) during the first 14 days of our study period, it is possible that the suboptimal temperatures may have inhibited drug absorption through the skin, systemic circulation, distribution, and/or metabolism in the tortoises. This theory can be supported by a previous study which showed that physiological performance and metabolism in reptiles are highly temperature dependent (Huey, 1982) ; another study also demonstrated that a decrease in temperature had a negative impact on cardiac performance in ectothermic vertebrates (Driedzic and Gesser, 1994) . Consequently, systemic circulation and distribution of emodepside and praziquantel may have been affected in our tortoise population kept at suboptimal temperatures. However, the housing condition used in our study reflects the situation for many captive tortoises in the UK, because a recent retrospective survey demonstrated that 59.6% of captive tortoises were kept outside in either an outdoor enclosure or free-ranging in the garden (Hedley et al., 2013) . Further study measuring the serum concentrations of emodepside in tortoises kept at different temperatures would provide valuable information on the possible impact of environmental conditions on the pharmacokinetics of Profender in tortoises. This may also help to determine the half-life and potential residual activity of emodepside in tortoises. Oxyurids in tortoises may also be less sensitive to emodepside under a suboptimal body temperature, but further research needs to be undertaken to justify this theory. It is important to note that fenbendazole has previously been shown to take at least 31 days to achieve the full effect in Hermann's tortoises (Giannetto et al., 2007) . Future study comparing the efficacy of Profender and fenbendazole is also warranted.
One of the most striking results to emerge from the present study is that 52% of our sample tortoise population showed no evidence of intestinal parasitism, despite the fact that 96.6% of them had not been dewormed in the preceding four years. This illustrates the limited requirement for routine anthelmintic treatment and confirms that the decision to deworm should depend upon fecal examination and the clinical status of a tortoise.
One of the limitations of the present study was the small sample size. It is also worth noting that the sampled population of tortoises could not be moved into a completely clean environment. Thus, reinfection could not be ruled out. The impact of reinfection on posttreatment FEC depends on the time of sampling and the prepatent period of the parasite. Although prepatent periods are highly variable between oxyurid species (Galvin, 1968; Taffs, 1976; Parsons, 1987; Baker, 2007; Reinemeyer et al., 2010) , and current knowledge is limited for parasites that infect tortoises, the sampling interval employed here was likely to have precluded completion of the prepatent period. All tortoises that were nematode positive during the prescreening were treated with Profender on ethical grounds, preventing inclusion of an untreated control group. Further study using a larger sample population and three day pooled samples is recommended. This can enhance the sensitivity of ova detection and overcome the potential variation in quantities of ova being shed by the nematodes.
One disadvantage of using Profender as an anthelmintic in tortoises is that it contains a fixed combination of emodepside, a broad spectrum nematocide, and praziquantel, which targets trematodes and cestodes. Although trematodes and cestodes have been infrequently detected in tortoises, they are suggested to be nonpathogenic (Rataj et al., 2011) . They also have indirect life cycles, with intermediate hosts required for replication; hence, they are rarely encountered in captive tortoises (Greiner and Mader, 2006; Rataj et al., 2011; Hedley et al., 2013) . As a result, there is generally no therapeutic indication for the use of praziquantel in most captive tortoises, even though it has been shown to be well tolerated.
Despite the delayed, moderate efficacy demonstrated in this study, caution should be exercised in applying this medication. Further research is needed to fully elucidate the safety and optimal dose(s) of Profender in different tortoise species, especially in diseased tortoises. It is possible that a higher or repeated dose of Profender may be able to provide sufficient anthelmintic activity (FECR ≥ 95%) against oxyurid and ascarid parasites in tortoises. Because of the relatively slow onset of effect of Profender shown in our study, the authors do not recommend treating tortoises with Profender within 30 days of hibernation so as to allow sufficient time for the killing process and ensure all dead nematodes are passed in feces.
conclusIons
Our findings showed moderate efficacy of Profender against oxyurid parasites in two species of tortoises. Although sufficient anthelmintic efficacy of Profender cannot be concluded from this study because FECR ≥ 95% was not achieved, one application of Profender to the prefemoral fossa at 1 mL/kg was effective in reducing the burden of the most common gastrointestinal nematode encountered in captive tortoises. Efficacy of Profender against ascarids cannot be concluded in this present study.
From our investigations, we can conclude that the topical application of Profender was well-tolerated, and no treatment-related adverse effects were observed on spur-thighed and Hermann's tortoises. The method of administration of Profender is advantageous; it provides a more practical option and a less stressful deworming experience for tortoises, especially in situations where oral administration is problematic. This topical preparation, containing a combination of emodepside and praziquantel, can be considered as an alternative treatment protocol to fenbendazole in tortoises, although independent clinical judgment is required when selecting the optimum anthelmintic for tortoises.
